These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 29378599)
1. miR-3928v is induced by HBx via NF-κB/EGR1 and contributes to hepatocellular carcinoma malignancy by down-regulating VDAC3. Zhang Q; Song G; Yao L; Liu Y; Liu M; Li S; Tang H J Exp Clin Cancer Res; 2018 Jan; 37(1):14. PubMed ID: 29378599 [TBL] [Abstract][Full Text] [Related]
2. HBx-induced MiR-1269b in NF-κB dependent manner upregulates cell division cycle 40 homolog (CDC40) to promote proliferation and migration in hepatoma cells. Kong XX; Lv YR; Shao LP; Nong XY; Zhang GL; Zhang Y; Fan HX; Liu M; Li X; Tang H J Transl Med; 2016 Jun; 14(1):189. PubMed ID: 27349221 [TBL] [Abstract][Full Text] [Related]
3. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5. Cao Y; Chen J; Wang D; Peng H; Tan X; Xiong D; Huang A; Tang H Oncotarget; 2015 Nov; 6(35):38093-106. PubMed ID: 26497554 [TBL] [Abstract][Full Text] [Related]
4. SPG21, a potential oncogene targeted by miR-128-3p, amplifies HBx-induced carcinogenesis and chemoresistance via activation of TRPM7-mediated JNK pathway in hepatocellular carcinoma. Zhou P; Yao W; Liu L; Yan Q; Chen X; Wei X; Ding S; Lv Z; Zhu F Cell Oncol (Dordr); 2024 Oct; 47(5):1757-1778. PubMed ID: 38753154 [TBL] [Abstract][Full Text] [Related]
5. Pleiotrophin, a target of miR-384, promotes proliferation, metastasis and lipogenesis in HBV-related hepatocellular carcinoma. Bai PS; Xia N; Sun H; Kong Y J Cell Mol Med; 2017 Nov; 21(11):3023-3043. PubMed ID: 28557334 [TBL] [Abstract][Full Text] [Related]
6. RPS3a over-expressed in HBV-associated hepatocellular carcinoma enhances the HBx-induced NF-κB signaling via its novel chaperoning function. Lim KH; Kim KH; Choi SI; Park ES; Park SH; Ryu K; Park YK; Kwon SY; Yang SI; Lee HC; Sung IK; Seong BL PLoS One; 2011; 6(8):e22258. PubMed ID: 21857917 [TBL] [Abstract][Full Text] [Related]
7. Epigenetic repression of miR-132 expression by the hepatitis B virus x protein in hepatitis B virus-related hepatocellular carcinoma. Wei X; Tan C; Tang C; Ren G; Xiang T; Qiu Z; Liu R; Wu Z Cell Signal; 2013 May; 25(5):1037-43. PubMed ID: 23376496 [TBL] [Abstract][Full Text] [Related]
8. Downregulation of MicroRNA-145 Caused by Hepatitis B Virus X Protein Promotes Expression of CUL5 and Contributes to Pathogenesis of Hepatitis B Virus-Associated Hepatocellular Carcinoma. Gao F; Sun X; Wang L; Tang S; Yan C Cell Physiol Biochem; 2015; 37(4):1547-59. PubMed ID: 26512974 [TBL] [Abstract][Full Text] [Related]
9. Hepatitis B virus X protein accelerates hepatocarcinogenesis with partner survivin through modulating miR-520b and HBXIP. Zhang W; Lu Z; Kong G; Gao Y; Wang T; Wang Q; Cai N; Wang H; Liu F; Ye L; Zhang X Mol Cancer; 2014 May; 13():128. PubMed ID: 24886421 [TBL] [Abstract][Full Text] [Related]
10. MiR-19a, miR-122 and miR-223 are differentially regulated by hepatitis B virus X protein and involve in cell proliferation in hepatoma cells. Yu G; Chen X; Chen S; Ye W; Hou K; Liang M J Transl Med; 2016 May; 14(1):122. PubMed ID: 27150195 [TBL] [Abstract][Full Text] [Related]
11. SHP2 is induced by the HBx-NF-κB pathway and contributes to fibrosis during human early hepatocellular carcinoma development. Kang HJ; Chung DH; Sung CO; Yoo SH; Yu E; Kim N; Lee SH; Song JY; Kim CJ; Choi J Oncotarget; 2017 Apr; 8(16):27263-27276. PubMed ID: 28460481 [TBL] [Abstract][Full Text] [Related]
12. Hepatitis B virus X protein boosts hepatocellular carcinoma progression by downregulating microRNA-137. Gao Y; Gu J; Wang Y; Fu D; Zhang W; Zheng G; Wang X Pathol Res Pract; 2020 Jun; 216(6):152981. PubMed ID: 32527447 [TBL] [Abstract][Full Text] [Related]
13. Upregulated microRNA-29a by hepatitis B virus X protein enhances hepatoma cell migration by targeting PTEN in cell culture model. Kong G; Zhang J; Zhang S; Shan C; Ye L; Zhang X PLoS One; 2011 May; 6(5):e19518. PubMed ID: 21573166 [TBL] [Abstract][Full Text] [Related]
14. NCAPG2 overexpression promotes hepatocellular carcinoma proliferation and metastasis through activating the STAT3 and NF-κB/miR-188-3p pathways. Meng F; Zhang S; Song R; Liu Y; Wang J; Liang Y; Wang J; Han J; Song X; Lu Z; Yang G; Pan S; Li X; Liu Y; Zhou F; Wang Y; Cui Y; Zhang B; Ma K; Zhang C; Sun Y; Xin M; Liu L EBioMedicine; 2019 Jun; 44():237-249. PubMed ID: 31176678 [TBL] [Abstract][Full Text] [Related]
15. A positive-feedback loop between HBx and ALKBH5 promotes hepatocellular carcinogenesis. Qu S; Jin L; Huang H; Lin J; Gao W; Zeng Z BMC Cancer; 2021 Jun; 21(1):686. PubMed ID: 34112124 [TBL] [Abstract][Full Text] [Related]
16. Hepatitis B virus X protein inhibits tumor suppressor miR-205 through inducing hypermethylation of miR-205 promoter to enhance carcinogenesis. Zhang T; Zhang J; Cui M; Liu F; You X; Du Y; Gao Y; Zhang S; Lu Z; Ye L; Zhang X Neoplasia; 2013 Nov; 15(11):1282-91. PubMed ID: 24339740 [TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus X protein promotes proliferation of hepatocellular carcinoma cells by upregulating miR-181b by targeting ING5. Xie X; Xu X; Sun C; Yu Z Biol Chem; 2018 May; 399(6):611-619. PubMed ID: 29604207 [TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus X protein promotes CREB-mediated activation of miR-3188 and Notch signaling in hepatocellular carcinoma. Zhou SJ; Deng YL; Liang HF; Jaoude JC; Liu FY Cell Death Differ; 2017 Sep; 24(9):1577-1587. PubMed ID: 28574502 [TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus X protein upregulates alpha-fetoprotein to promote hepatocellular carcinoma by targeting miR-1236 and miR-329. Zhang C; Liu P; Zhang C J Cell Biochem; 2020 Mar; 121(3):2489-2499. PubMed ID: 31680299 [TBL] [Abstract][Full Text] [Related]
20. TRERNA1 upregulation mediated by HBx promotes sorafenib resistance and cell proliferation in HCC via targeting NRAS by sponging miR-22-3p. Song W; Zheng C; Liu M; Xu Y; Qian Y; Zhang Z; Su H; Li X; Wu H; Gong P; Li Y; Fan H Mol Ther; 2021 Aug; 29(8):2601-2616. PubMed ID: 33839325 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]